Statera Gets FDA OK to Proceed With Radiation Rescue Drug Development

The FDA has lifted the clinical hold it placed in 2019 on the research and development of Entolimod for acute radiation syndrome (ARS), allowing new owner Statera Biopharma to proceed with plans to look at the molecule in cancer patients.
Source: Drug Industry Daily